Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 2/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27761768 | 0.84 | ACE2 (0.52) | FAAHACE2ZDHHC7ALDH1A1MAPT | |
| SCHEMBL16556659 | 0.84 | ACE2 (0.52) | FAAHACE2ZDHHC7ALDH1A1MAPT | |
| SCHEMBL28323464 | 0.84 | ACE2 (0.52) | FAAHACE2ZDHHC7ALDH1A1MAPT | |
| SCHEMBL4585164 | 0.84 | ACE2 (0.52) | FAAHACE2ZDHHC7ALDH1A1MAPT | |
| SCHEMBL27257661 | 0.84 | ACE2 (0.52) | FAAHACE2ZDHHC7ALDH1A1MAPT | |
| SCHEMBL14525664 | 0.82 | FAAH (0.49) | FAAHACE2ZDHHC7ALDH1A1MAPT | |
| SCHEMBL2853552 | 0.78 | MAPT (0.57) | ACE2ALDH1A1MAPT | |
| SCHEMBL11821362 | 0.77 | ALDH1A1 (0.50) | FAAHACE2ALDH1A1MAPTPRKCA | |
| SCHEMBL1476651 | 0.76 | ACE2 (0.56) | FAAHACE2MAPT | |
| SCHEMBL1477205 | 0.76 | ACE2 (0.56) | FAAHACE2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1913008-B1 | Cyclic olefin polymerisation process | LG CHEMICAL LTD (KR) | 2015-04-01 | — | — | EP | disclosed |
| US-7638653-B2 | Method of preparing phosphonium compound for cyclic olefin polymerization | LG CHEM, LTD. (KR) | 2009-12-29 | — | — | US | disclosed |
| EP-1913008-A1 | METHOD OF PREPARING PHOSPHONIUM COMPOUND FOR CYCLIC OLEFIN POLYMERIZATION | LG Chem, Ltd. (KR) | 2008-04-23 | — | — | EP | disclosed |
| US-20070027277-A1 | Method of preparing phosphonium compound for cyclic olefin polymerization | LG CHEM, LTD (PROSECUTION) (KR) | 2007-02-01 | — | — | US | disclosed |
| WO-2007013759-A1 | METHOD OF PREPARING PHOSPHONIUM COMPOUND FOR CYCLIC OLEFIN POLYMERIZATION | LG CHEM, LTD. (KR) | 2007-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027277-A1 | Method of preparing phosphonium compound for cyclic olefin polymerization | OXSR1, POLR2A, POLR2B | FAAH 2257/4885ACE2 4431/4885ZDHHC7 1278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.